SOSandra Helena Penha Oliveira

Sandra Helena Penha Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Helena Penha Oliveira has a total of 380 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Foetal Development and Placental Health in Response to Apical Periodontitis Induced in Pregnant Wistar Rats

    by Ana Carla Thalez Ywabuchi Nobumoto, Thais Verônica Saori Tsosura, Maria Sara de Lima Coutinho Mattera, Bianca Elvira Belardi, Anna Clara Cachoni, Rodrigo Martins dos Santos, Bruna de Oliveira Alves, Lorena Umbelino Rodrigues, Juliane Stephanie Mendonça Rodrigues, Sandra Helena Penha Oliveira, et al.

    Aim: This study investigates the relationship between maternal apical periodontitis (AP) and neonatal health. Methodology: Twenty‐four Wistar rats were assigned to three groups: control (CN), one induced apical periodontitis (AP1), and four induced apical periodontitis (AP4). Apical periodontitis was induced for all experimental groups. After 30 days, the rats were mated and sacrificed on the 21st day of gestation. Placental weight, maternal glycemia, insulinemia, insulin resistance, and placental protein levels were analysed. Neonates were evaluated for their number, weight, capillary glycemia, and liver tumour necrosis factor‐α (TNF‐α) content. Results: The results showed that no significant differences were observed in maternal glycemia. However, insulinemia and homeostatic model assessment for insulin resistance were higher in the AP groups compared with CN and were more pronounced in AP4 than AP1. Placental weight and placental labyrinth area were reduced exclusively in the AP4 group, while the number of fetuses per rat did not differ among groups. The AP4 group exhibited increased placental TNF‐α gene expression and protein content compared with CN and AP1. In addition, placental caspase‐3 expression was increased in the AP4 group, with no significant differences in nuclear factor‐kappaB (p50 and p65) phosphorylation status among groups. Foetal analyses demonstrated a reduction in naso‐anal length in fetuses from the AP4 group, lower capillary glycemia in fetuses from AP rats compared with CN, and increased TNF‐α content in foetal liver tissue from AP groups. Conclusions: Overall, most alterations were more pronounced with an increasing number of maternal teeth affected by AP, emphasizing the importance of maternal oral health in preventing placental dysfunction and adverse fetal developmental outcomes.


  • Open Access

    Can angiotensin II affect the inflammatory response of human dental pulp cells in vitro?

    by Bella Luna Colombini-Ishikiriama, Thiago José Dionisio, Thais Francini Garbieri, Rafaela Alves da Silva, Sandra Helena Penha Oliveira, Vanessa Soares Lara, Andrew Seth Greene, Carlos Ferreira dos Santos

    Dental pulp fibroblasts respond to various stimuli, including microbial agents, endodontic materials, restorative procedures, pulp protection treatments, and inflammatory molecules. Its inflammatory response to injury involves a complex set of mechanisms that have been increasingly studied for their roles in this intricate biological process. Among these mechanisms is angiotensin II (ANG-II), the involvement of which in inflammation has been shown in several pathological conditions via its local generation and action. Objective This study aimed to evaluate the capacity of fibroblasts from permanent and deciduous dental pulp to express inflammatory mediators when exposed to bacterial and inflammatory antigens. It also sought to assess the presence of components of the renin-angiotensin system (RAS) and the potential modulatory role of ANG-II in this response. Methodology Fibroblasts were cultured from the pulp of permanent and deciduous teeth obtained from three adult and four pediatric donors with informed consent. Cells were stimulated with Porphyromonas gingivalis and Escherichia coli lipopolysaccharides (LPS) either alone or in combination with ANG-II and, in some cases, with IL-1β. Gene expression of RAS components and various inflammatory mediators was analyzed by qRT-PCR. ANG-II receptor expression was quantified by flow cytometry. Results The results showed that both bacterial antigens and IL-1β significantly upregulated the expression of genes encoding key inflammatory mediators. However, ANG-II, either alone or in combination with other antigens, failed to alter the expression levels of these mediators. Conclusion These findings clearly show that ANG-II has no influence on the expression of inflammatory mediators by human dental pulp fibroblasts under the tested conditions.

  • MicroRNA‐127‐3p Inhibits In Vitro Osteogenesis and Dampens Trauma‐Induced Heterotopic Ossification In Vivo

    by Victor Gustavo Balera Brito, Austin Bell‐Hensley, Hongjun Zheng, Jin Liu, Arya Narayan, Sandra Helena Penha Oliveria, Hua Pan, Audrey McAlinden

    MicroRNAs are small non‐coding RNAs that regulate cellular pathways by targeting multiple mRNAs, playing critical roles in skeletal development and homeostasis. Our previous miRNA profiling studies identified higher levels of miR‐127‐3p in the hypertrophic zone of developing human growth plates while another group found this miRNA to be more highly expressed in murine hindlimb cartilage compared to calvarial bone. Other published work revealed elevated circulating miR‐127‐3p levels in osteoporotic patients and in long bones of ovariectomized mice. Collectively, these findings suggest a role for miR‐127‐3p in regulating bone formation. To fill a knowledge gap, we designed a study to determine the function of miR‐127‐3p in regulating osteogenic differentiation of human bone marrow‐derived mesenchymal stromal cells (hBMSCs). While inhibition of miR‐127‐3p had no effect, mimic overexpression robustly inhibited in vitro osteogenesis. Bulk RNA‐sequencing showed a number of cellular pathways affected, including suppression of proliferation‐related pathways, which was confirmed by decreased BrdU incorporation. To assess the translational potential of the bone suppressing function of this miRNA, we utilized a pre‐clinical mouse model of trauma‐induced heterotopic ossification involving Achilles tendon transection. Local delivery of miR‐127‐3p mimics via peptide‐based nanoparticle technology significantly reduced ectopic bone formation at the proximal site of the transected tendon. These studies demonstrate that approaches to overexpress miR‐127‐3p and induce bone suppressing activity may be of therapeutic value as a means to treat many forms of heterotopic ossification.

  • Open Access

    Response of cultured primary gingival and periodontal ligament cells to angiotensin II and IL1β challenges

    by Thais Francini Garbieri, Thiago José Dionísio, Bella Luna Colombini-Ishikiriama, Rafaela Alves da Silva, Vanessa Soares Lara, Sandra Helena Penha Oliveira, Maria Helena Fernandes, Andrew Seth Greene, Carlos Ferreira Santos

    Angiotensin II (Ang II) releases inflammatory mediators from several cell types. The objective of this study was to investigate the potential of Ang II to induce mRNA expression of inflammatory mediators in primary cultured fibroblast-like cells isolated from gingival and periodontal ligament tissues. A synergistic effect of co-treatment with Ang II and Interleukin-1β (IL1β) on the mRNA expression of inflammatory mediators was explored. Immunophenotyping of STRO-1, Ang II type 1 receptor (AT1R), and Ang II type 2 receptor (AT2R) was performed using flow cytometry. Cell cultures were challenged with Ang II (1 µM) for 3, 6, and 24 h with or without co-treatment with IL1β (0.1 ng/mL) for 24 h. mRNA expression of inflammatory mediators was determined using qPCR. We present, for the first time, precise quantification of AT1R and AT2R in human gingival and periodontal fibroblast-like cell types; the percentage of positive immunostaining compared to the total cell population varied from 3.35% to 5.29% for AT1R and 2.97% to 4.57% for AT2R. Ang II slightly upregulated IL6 and CCL2/MCP1 mRNA expression in gingival cells and IL8 and PTGS2/COX2 in periodontal ligament cells. IL1β upregulated IL8, IL6, CCL2/MCP1, PTGS2/COX2, and IL1β mRNA in both cell types. Co-treatment with Ang II and IL1β did not show a synergistic effect. Ang II showed a low potential to induce mRNA of inflammatory mediators, most likely owing to the low percentage of Ang II receptors in such cells and no synergistic effect with the co-treatment with IL1β.


  • Open Access

    Correction: Santos et al. Early Peri-Implant Bone Healing on Laser-Modified Surfaces with and without Hydroxyapatite Coating: An In Vivo Study. Biology 2024, 13, 533

    by Ana Flávia Piquera Santos, Rodrigo Capalbo da Silva, Henrique Hadad, Laís Kawamata de Jesus, Maísa Pereira-Silva, Heloisa Helena Nímia, Sandra Helena Penha Oliveira, Antônio Carlos Guastaldi, Thallita Pereira Queiroz, Pier Paolo Poli, et al.

    There were two errors in the original publication


  • Evaluation of the systemic effect of bone formation marker released by endodontic calcium silicate-based sealers in local tissues, the bloodstream, and body organs

    by Índia Olinta De Azevedo Queiroz, Wagner Garcez de Mello, Thiago Machado, Maria Carolina Guiotti de Oliveira, Bruno Carvalho Vasconcelos, Sandra Helena Penha de Oliveira, Marco Antonio Hungaro Duarte

    Calcium silicate-based sealers are bioactive materials that release ions when in contact with body fluids. Therefore, this study aims mapping/trace bone formation markers released by MTA Fillapex, BioRoot RCS, and experimental tricalcium silicate-based sealer (CEO) into subcutaneous tissues, bloodstream and body organs. Toward, polyethylene tubes filled with sealers were implanted into connective tissue of Wistar rats. On days 7, 15, 30, and 45 after implantation, blood samples were collected to measure calcium (Ca2+), phosphorus (P), and alkaline phosphatase (ALP) levels. Thereafter, the animals were killed, and the brain, liver, kidneys, and subcutaneous tissue were removed and processed to determine the concentrations of Ca2+ and P by ICP-OES. Similar Ca2+ levels were observed in subcutaneous tissue for all groups, although, at 45 days, it was identified a reduction in Ca2+ serum levels of CEO compared to those two other sealers and an increase in Ca2+ levels in the liver compared to those released by MTA Fillapex. In contrast, no trace of P was detected in any tissue; moreover, plasma P and ALP serum levels of MTA Fillapex were higher at day 30. Our findings showed that Ca2+ were identified in local tissues, bloodstream, and organs from all sealers. The up-regulation of bone marker levels promoted by sealers can modify body homeostasis and induce tissue damage. Besides, MTA Fillapex was associated with a raise of bone marker levels, suggesting a possible systemic effect. The sealer composition can affect not only the local repair process but also the systemic health.


  • Open Access

    Early Peri-Implant Bone Healing on Laser-Modified Surfaces with and without Hydroxyapatite Coating: An In Vivo Study

    by Ana Flávia Piquera Santos, Rodrigo Capalbo da Silva, Henrique Hadad, Laís Kawamata de Jesus, Maísa Pereira-Silva, Heloisa Helena Nímia, Sandra Helena Penha Oliveira, Antônio Carlos Guastaldi, Thallita Pereira Queiroz, Pier Paolo Poli, et al.

    (1) Objective: The aim of this study was to assess the biological behavior of bone tissue on a machined surface (MS) and modifications made by a laser beam (LS) and by a laser beam incorporated with hydroxyapatite (HA) using a biomimetic method without thermic treatment (LHS). (2) Methods: Scanning electron microscopy coupled with energy-dispersive X-ray spectrometry (SEM/EDX) was performed before and after installation in the rabbit tibiae. A total of 20 Albinus rabbits randomly received 30 implants of 3.75 × 10 mm in the right and left tibias, with two implants on each surface in each tibia. In the animals belonging to the 4-week euthanasia period group, intramuscular application of the fluorochromes calcein and alizarin was performed. In implants placed mesially in the tibiofemoral joint, biomechanical analysis was performed by means of a removal torque (N/cm). The tibias with the implants located distally to the joint were submitted for analysis by confocal laser microscopy (mineral apposition rate) and for histometric analysis by bone contact implant (%BIC) and newly formed bone area (%NBA). (3) Results: The SEM showed differences between the surfaces. The biomechanical analysis revealed significant differences in removal torque values between the MSs and LHSs over a 2-week period. Over a 4-week period, both the LSs and LHSs demonstrated removal torque values statistically higher than the MSs. BIC of the LHS implants were statistically superior to MS at the 2-week period and LHS and LS surfaces were statistically superior to MS at the 4-week period. Statistical analysis of the NBA of the implants showed difference between the LHS and MS in the period of 2 weeks. (4) Conclusions: The modifications of the LSs and LHSs provided important physicochemical modifications that favored the deposition of bone tissue on the surface of the implants.


  • Open Access

    Response of Cultured Primary Human Gingival and Periodontal Ligament Cells to Angiotensin II and IL1β Challenges

    by Thais Francini Garbieri, Thiago José Dionísio, Bella Luna Colombini-Ishikiriama, Rafaela Alves da Silva, Vanessa Soares Lara, Sandra Helena Penha de Oliveira, Maria Helena Fernandes, Andrew Seth Greene, Carlos Ferreira Santos

    Angiotensin II (Ang II) plays a role in several inflammatory diseases and is capable of inducing the release of inflammatory mediators in several cell types. The objective was to investigate the potential of Ang II to induce mRNA expression of inflammatory mediators by cultured primary human periodontal cells. A synergistic effect of a co-treatment with Ang II and IL1β on mRNA expression of inflammatory mediators was also explored. Primary cultures of human fibroblast-like cells isolated from gingival and periodontal ligament tissues from 3 subjects were established using explant techniques. Immunophenotyping of STRO-1, Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R) was performed by flow cytometry analysis. Cell cultures were challenged with Ang II (1M) for 3, 6 and 24h with or without a co-treatment with IL1β (0.1ng/mL) for 24h. mRNA expression of inflammatory mediators was performed by real time quantitative polymerase chain reaction (RT-qPCR). We present, for the first time, a precise quantification for AT1R and AT2R on human gingival and periodontal fibroblast-like cell types; the percentage of positive immunostaining compared to the total population of cells varied from 3.35% through 5.29% for AT1R and 2.97% through 4.57% for AT2R. Ang II slightly upregulated mRNA expression of IL6 and CCL2/MCP1 in gingival cells and IL8 and PTGS2/COX2 in periodontal ligament cells. IL1β induced upregulation of IL8, IL6 CCL2/MCP1, PTGS2/COX2 and IL1β mRNA in both cell types. Co-treatment with Ang II and IL1β did not show a synergistic effect under these experimental conditions. Ang II shows a low potential to induce mRNA upregulation of inflammatory mediators in cultured primary human gingival and periodontal ligament cells, most likely due to the low percentage of Ang II receptors in such cells, and no synergistic effect with the co-treatment with IL1β.

  • Open Access

    Cytotoxicity of cleaning agents for ocular prostheses

    by Marcelo Goiato, Agda Marobo, Fernanda Caxias, Emily da Silva, Letícia Gonçalves, Sandra Oliveira, Victor Brito, Clóvis Lamartine de Moraes Melo Neto, Daniela dos Santos

    Polymethylmethacrylate (PMMA) is the most used material for the manufacturing of eye prostheses. To investigate the cytotoxicity of different cleaning agents for ocular prostheses on human conjunctival cells. Six groups of specimens were created (saline, soap, 4% chlorhexidine, hydrogen peroxide, 1% triclosan, and citronella oil). Three specimens were made for each disinfectant at each disinfection period (1, 7, 15, 30, 60, and 90 days), totaling 108 specimens. Thus, the specimens were disinfected, with different disinfectants, for different periods of time. After each disinfection process, the specimens were washed with sterile distilled water. A human conjunctival cell line was grown on the acrylic resin specimens and then cytotoxicity tests (MTT and Neutral Red (NR)) were performed. A negative control (untreated cell cultures) and positive control (Tween 20) were created. Two-way analysis of variance (ANOVA) and Bonferroni test were performed (p < 0.05). For the MTT and NR tests, when there was a significant difference between the disinfectant and negative control, the disinfectant generated a significant reduction in cell proliferation most of the time. All reductions in cell proliferation caused by the disinfectants were clinically acceptable. All disinfectants tested in this study were found to be non-cytotoxic to human conjunctival cells.


  • Losartan Plays a Fungistatic and Fungicidal Activity Against Candida albicans Biofilms: Drug Repurposing for Localized Candidosis

    by Vanessa Soares Lara, Rafaela Alves da Silva, Tatiane Ponteado Ferrari, Carlos Ferreira dos Santos, Sandra Helena Penha de Oliveira

    Candidosis is one of the most frequent opportunistic infections and exhibits variable clinical presentations, including oral localized forms. Drugs affecting the renin-angiotensin system targets inhibit secreted aspartic proteases from Candida albicans. The objective of the study was to evaluate whether losartan has antimicrobial action against C. albicans biofilms. Biofilms were treated with losartan or aliskiren (for comparison) for 24 h. Metabolic activity of viable cells and growth inhibition of C. albicans biofilms were assessed using XTT [2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenyl-Amino)Carbonyl]-2H-Tetrazolium Hydroxide] and colony-forming unit assays, respectively. In addition, the cytotoxicity of the drugs on human cells was evaluated using the AlamarBlue assay. Both drugs decreased fungal viability at all concentrations. In addition, all concentrations of losartan inhibited the growth of C. albicans biofilm, ranging from 47% to 88.5%, whereas aliskiren showed inhibition from 1 to 10 mg/mL, which ranged from 16% to 97.6%. Furthermore, at certain concentrations, these drugs maintained the viability of human cells. Losartan and aliskiren have fungistatic and fungicidal action against C. albicans biofilms and are compatible with human cells. Therefore, these antihypertensive drugs can be repurposed to interfere with the metabolism and development of Candida biofilms, which are widely associated with clinical forms of candidosis, including oral localized forms such as denture stomatitis.